Instil Bio Balance Sheet Health
Financial Health criteria checks 5/6
Instil Bio has a total shareholder equity of $205.8M and total debt of $81.7M, which brings its debt-to-equity ratio to 39.7%. Its total assets and total liabilities are $306.3M and $100.5M respectively.
Key information
39.7%
Debt to equity ratio
US$81.68m
Debt
| Interest coverage ratio | n/a |
| Cash | US$153.79m |
| Equity | US$205.83m |
| Total liabilities | US$100.48m |
| Total assets | US$306.30m |
Financial Position Analysis
Short Term Liabilities: TIL's short term assets ($161.0M) exceed its short term liabilities ($11.4M).
Long Term Liabilities: TIL's short term assets ($161.0M) exceed its long term liabilities ($89.1M).
Debt to Equity History and Analysis
Debt Level: TIL has more cash than its total debt.
Reducing Debt: Insufficient data to determine if TIL's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TIL has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TIL has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 13.4% each year.